Google
Trusted Resources: News & Events
Latest announcements and gatherings
Kids Who Need Sickle Cell Meds Don’t Always Get Them
Less than a fifth of U.S. children with sickle cell anemia are getting the antibiotics that could save their lives, a new study finds.
“Longstanding recommendations say children with sickle cell anemia should take antibiotics daily for their first five years of life,” the study’s lead author, Sarah Reeves, said in a news release from Michigan Medicine.
These antibiotics can protect the children against potentially deadly infections, Reeves said. She’s an epidemiologist with the Child Health Evaluation and Research Center at the University of Michigan Medical School.
Bacterial infections are a major health threat for children with sickle cell anemia, but taking daily antibiotics can reduce that risk by 84 percent, according to the study.
However, the researchers found that just 18 percent of children with the blood disorder were taking antibiotics daily.
+myBinderRelated Content
-
Gene therapy may help cure sickle cell disease, study saysA gene therapy that could provide a perm...
-
NIH Launches new Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global ScaleThe National Institutes of Health plans ...
-
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
-
Allogeneic stem cell transplantation for sickle cell diseasePURPOSE OF REVIEW: As the safety and ava...
-
Opioid utilization patterns in United States patients with sickle cell diseaseSickle cell disease (SCD) is the most co...
-
FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
The Life, Death, and Dream of a Research Diversity Crusader“We want to have a nation in which the...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.